Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Genomics-Based Medicine Coming into View

1,184 views

Published on

NextCODE’s interpretation technology will be an increasingly important asset in delivering insights from the wealth of genomic data being produced.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Genomics-Based Medicine Coming into View

  1. 1. Genomics-Based Medicine Coming into View Hannes Smarason Genome Sequencing |Personalized Medicine | Transforming Health Care
  2. 2. The practice and adoption of genomic medicine is accelerating as technologies improve, costs fall and new insights drive better patient care. While many companies are supporting this emerging field, a select few are providing the unique perspectives and capabilities to advance progress even faster.
  3. 3. Progress in Action • NextCODE Health made headlines less than a year ago with its launch and funding announcement. • The company quickly gained recognition for its unique capabilities to address unmet needs in the genomics space through a massive genomics database that interprets DNA samples to identify relevant disease markers. (See the features in Xconomy, Bio-IT World and PLOS Blog.) • The company was later mentioned in Nature Biotechnology News for its potential contributions to genome studies by leveraging reference data from deCODE’s Icelandic database.
  4. 4. Accelerating Progress • Its rapid trajectory since launch and the utility of its genomic analysis technology was featured in BioCentury in May, with testimonials from clinicians using NextCODE capabilities. • In June, it was featured in a major interview with Bio-IT World, and the company continues to expand. • Since then, NextCODE has announced several programs through which world leaders in genomics research are applying its interpretation and analysis technology: – A collaboration with the ANZAC Research Institute in Sydney Australia to use NextCODE’s technology to research a rare disease, X-linked Charcot-Marie- Tooth syndrome – And a new program with University College Dublin’s ACoRD to study autism and rare diseases
  5. 5. As more organizations employ genomics in major research initiatives, NextCODE’s interpretation technology will be an increasingly important asset in delivering meaningful insights from the wealth of genomic data being produced.

×